Coherus Oncology Inc (CHRS)

Revenue

$14.31M

Quarterly · Period ending: · USD

CHRS logo

CHRS Revenue

Latest reported$14.31M
CHRS Quarterly Revenue ($506.00K → $14.31M)
High-resolution chart · PNG

CHRS revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Revenue — Quarterly (USD)
Period endingRevenue (USD)
14,307,000
12,310,000
12,748,000
11,571,000
10,254,000
7,599,000
54,144,000
70,774,000
64,979,000
2,308,000
91,524,000
74,568,000
58,716,000
32,436,000
45,352,000
45,424,000
60,151,000
60,115,000
73,371,000
82,503,000
87,643,000
83,034,000
110,419,000
113,551,000
135,674,000
116,180,000
123,856,000
111,684,000
83,433,000
37,098,000
0
0
0
0
0
0
1,395,000
161,000
844,000
162,835,000
14,068,000
12,359,000
10,198,000
7,167,000
6,866,000
5,810,000
6,493,000
16,052,000
4,965,000
3,596,000
1,232,000
506,000
507,000
506,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.